News from boehringer ingelheim A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 09, 2019, 15:37 ET Boehringer Ingelheim Completes Plant Expansion After $76 Million Georgia Investment

Boehringer Ingelheim, a leading provider of animal health products for pets and livestock, marked the completion of work Wednesday after a $76...


Sep 26, 2019, 08:00 ET Boehringer Ingelheim donates vaccines to help fight rabies

Boehringer Ingelheim, a global leader in veterinary rabies vaccines2, plans to donate 60,000 doses of its IMRAB® rabies vaccine for dogs over the...


Sep 10, 2019, 08:00 ET How to Protect Your Dog from Lyme disease

Lyme disease in dogs is caused by one of the fastest-growing tick-transmitted bacterial infections in the United States – and it can cause major...


Aug 15, 2019, 16:33 ET Vendas líquidas da Boehringer Ingelheim atingem 9,3 bilhões de euros no primeiro semestre de 2019

A Boehringer Ingelheim, uma das 20 principais companhias farmacêuticas do mundo, encerrou o primeiro semestre de 2019 com resultados positivos nas...


Aug 01, 2019, 07:00 ET No Dia Mundial do Combate ao Câncer de Pulmão, Boehringer Ingelheim alerta sobre a importância do atendimento domiciliar para pacientes oncológicos

Com 600 mil novos casos no Brasil por ano entre 2018-2019, o câncer figura como uma das principais causas de morte no mundo. Entre os mais...


Mar 07, 2019, 08:00 ET Novel antibody shows potential to transform treatment of rare form of psoriasis

The New England Journal of Medicine (NEJM) today published new data from a Phase I clinical trial showing BI 655130, a first-in-class investigational ...


Jan 29, 2019, 11:56 ET Everett Hoekstra Appointed President of Boehringer Ingelheim Animal Health USA Inc.

Boehringer Ingelheim Animal Health USA Inc. announced today the appointment of Everett Hoekstra as its president. Hoekstra succeeds Paul Fonteyne,...


Jan 15, 2019, 10:29 ET Pacientes com arritmia grave anseiam por tratamento moderno no SUS

Quando o coração bate fora de ritmo diz-se que a pessoa apresenta uma arritmia cardíaca. É diferente da aceleração do coração de quando praticamos...


Nov 08, 2018, 12:36 ET Vai-Vai é destaque de campanha no Dia Nacional de Prevenção das Arritmias Cardíacas e Morte Súbita

A Fibrilação Atrial (FA) é uma doença que aumenta em cinco vezes o risco de AVC e acomete entre 1,5 e 2 milhões de brasileiros¹. No Dia Nacional de...


Oct 30, 2018, 15:27 ET Cérebro gigante, game educativo e blecaute marcam o Dia Mundial do AVC

Nesta segunda-feira (29/10), em alusão ao Dia Mundial do AVC, a estação Clínicas do metrô, em São Paulo (SP), foi palco da ação "Que doença é esta?". ...


Sep 12, 2018, 09:00 ET Boehringer Ingelheim To Donate 75,000 Doses Of Rabies Vaccine To The Global Alliance For Rabies Control Through Shots For Good Initiative

Merial, now part of Boehringer Ingelheim, announced today it will donate 75,000 doses of rabies vaccine to the Global Alliance for Rabies Control...


Aug 27, 2018, 11:48 ET FDA approves NexGard® (afoxolaner) for the prevention of infections that cause Lyme disease in dogs

Merial, now part of Boehringer Ingelheim, received approval from the U.S Food and Drug Administration (FDA) to expand the label claims for NexGard...


Aug 20, 2018, 10:00 ET Boehringer Ingelheim Announces The Launch Of CENTRAGARD™ (eprinomectin and praziquantel transdermal solution), Innovative Internal Parasite Protection For Cats

Heartworm disease is a serious and potentially deadly threat to cats. Heartworms are difficult to diagnose in cats, and there is no approved...


Aug 06, 2018, 10:05 ET Annual National Veterinary Scholars Symposium Showcases Young Talent And Value Of Hands-On Research Opportunities For Students

More than 650 veterinary students from across North America and Europe, as well as animal health researchers and leaders from more than three dozen...


Jul 18, 2018, 09:05 ET Governo avalia a incorporação de medicamento para Fibrose Pulmonar Idiopática

Fibrose Pulmonar Idiopática (FPI) é uma doença rara e progressiva que prejudica a capacidade pulmonar dos pacientes, apresentando taxa de sobrevida...


May 07, 2018, 01:30 ET Boehringer Ingelheim apresenta excelentes resultados em 2017

A Boehringer Ingelheim (BI) alcançou excelentes resultados financeiros em 2017, apresentados na Conferência Anual, na Alemanha. Todas as divisões de...


May 04, 2018, 08:00 ET Praxbind®, Specific Reversal Agent for Pradaxa®, Now Available in 3,200 Hospitals Nationwide

Today, Boehringer Ingelheim announced that Praxbind® (idarucizumab), a specific reversal agent for Pradaxa® (dabigatran etexilate mesylate), is now...


Apr 17, 2018, 08:00 ET FDA Provides Full Approval to Praxbind, Specific Reversal Agent for Pradaxa

Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has provided full approval for Praxbind® (idarucizumab), the...


Mar 14, 2018, 06:28 ET Boehringer Ingelheim y la Universidad de Vanderbilt amplían su colaboración en nuevos enfoques de tratamiento oncológico

- Boehringer Ingelheim y la Universidad de Vanderbilt amplían su colaboración para desarrollar nuevos enfoques de tratamiento oncológico --...


Mar 13, 2018, 09:49 ET Spoločnosť Boehringer Ingelheim a Univerzita Vanderbilt rozširujú svoje partnerstvo s cieľom vyvíjať nové spôsoby onkologickej liečby

Spoločnosť Boehringer Ingelheim a Univerzita Vanderbilt dnes oznámili, že nadviažu na svoju úspešnú spoluprácu z minulosti a budú spoločne vyvíjať...


Mar 13, 2018, 09:42 ET Boehringer Ingelheim i Uniwersytet Vanderbilt poszerzają współpracę w celu opracowania nowatorskich podejść do walki z rakiem

Koncern Boehringer Ingelheim i Uniwersytet Vanderbilt ogłosiły dziś poszerzenie dotychczasowej, pomyślnej współpracy w celu opracowania nowatorskich...


Mar 13, 2018, 09:00 ET Boehringer Ingelheim и Университет Вандербильта расширяют партнёрство в сфере разработки новых методов лечения рака

Boehringer Ingelheim и Университет Вандербильта сегодня сообщили о расширении существующего партнёрства в сфере разработки инновационных...


Mar 13, 2018, 09:00 ET Boehringer Ingelheim and Vanderbilt University Expand Partnership to Develop Novel Treatment Approaches for Cancer

Boehringer Ingelheim and Vanderbilt University today announced the expansion of their successful existing collaboration to develop novel anti-cancer...


Mar 13, 2018, 04:46 ET Boehringer Ingelheim et l'Université Vanderbilt élargissent leur partenariat afin de mettre au point de nouvelles méthodes de traitement du cancer

Boehringer Ingelheim et l'Université Vanderbilt ont annoncé aujourd'hui leur intention de renforcer leur collaboration afin de mettre au point de...


Feb 28, 2018, 07:29 ET 28 de fevereiro: Dia Mundial das Doenças Raras: Doença pulmonar rara requer diagnóstico precoce

Definida como uma doença rara, crônica e progressiva, a Fibrose Pulmonar Idiopática (FPI) afeta os pulmões, causando cicatrizes (fibroses). Visando...